Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo

Archives of General Psychiatry
W K GoodmanD S Charney

Abstract

A six- to eight-week double-blind placebo-controlled trial of the potent and selective serotonin reuptake inhibitor fluvoxamine was conducted in 42 patients with primary obsessive-compulsive disorder (OCD). Approximately one half of the patients also had symptoms of major depression. Fluvoxamine was significantly better than placebo on all measures of obsessive-compulsive symptoms. Nine of 21 patients were responders ("much improved") with fluvoxamine compared with no responders with placebo, and fluvoxamine was effective in patients with OCD both with and without secondary depression. Response of OCD was not correlated with severity of baseline depression. These data lend partial support to the serotonin hypothesis of OCD. However, since a number of patients failed to respond to fluvoxamine, the role of other neurochemical systems in this disorder needs to be explored.

Citations

Jul 1, 1991·Acta Psychiatrica Scandinavica·B VitielloE Friedman
Dec 1, 1990·Journal of Autism and Developmental Disorders·C J McDougleW K Goodman
Jan 1, 1990·Annals of the New York Academy of Sciences·T R InselD L Murphy
Jan 1, 1989·Acta Psychiatrica Scandinavica. Supplementum·S A Montgomery
Jul 1, 1993·Journal of Child and Adolescent Psychiatric and Mental Health Nursing·L ScahillK E Tynan
May 1, 1994·Psychiatry·P R MunfordR P Liberman
Nov 1, 1993·The International Journal of Eating Disorders·L K HsuT Weltzin
Aug 1, 1997·Journal of Clinical Psychopharmacology·M A StanleyL Reich
Jun 5, 2001·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·G Francobandiera
Jul 19, 2001·International Clinical Psychopharmacology·D MarazzitiG B Cassano
Mar 23, 2002·Journal of Clinical Psychopharmacology·Richard BergeronVratislav Hadrava
Apr 17, 2003·Proceedings of the National Academy of Sciences of the United States of America·Matthew W StateDavid C Ward
Apr 30, 2005·The Australian and New Zealand Journal of Psychiatry·Richard J KeunemanDavid J Castle
Feb 7, 2008·The Cochrane Database of Systematic Reviews·G M SoomroM Oakley-Browne
Jan 28, 2010·Expert Opinion on Pharmacotherapy·Donatella Marazziti, Giorgio Consoli
Feb 9, 2012·Postgraduate Medicine·Joseph F McGuireEric A Storch
Oct 23, 2012·Psychopharmacology·Nobuaki EgashiraMichihiro Fujiwara
Mar 28, 2013·Depression and Anxiety·Michael H BlochChristopher Pittenger
Feb 1, 2015·The International Journal of Neuropsychopharmacology·Darin D DoughertyNancy J Keuthen
Feb 14, 2015·Human Psychopharmacology·Daniele SerataAntonio Del Casale
Nov 1, 1994·Biomedical Chromatography : BMC·S H WongR Fernandes
Jul 1, 1994·The Annals of Pharmacotherapy·A Dorevitch, H Davis
Jan 1, 1994·European Archives of Psychiatry and Clinical Neuroscience·F HohagenM Berger
Jan 1, 1996·Journal of Child and Adolescent Psychiatric Nursing : Official Publication of the Association of Child and Adolescent Psychiatric Nurses, Inc·L Scahill
Feb 1, 1997·Journal of Clinical Psychopharmacology·E MundoE Smeraldi
Sep 1, 1995·Movement Disorders : Official Journal of the Movement Disorder Society·R A Hauser, T A Zesiewicz
Nov 1, 1995·Journal of Neurology, Neurosurgery, and Psychiatry·P K McGuire
Apr 1, 1996·Journal of Clinical Psychopharmacology·L M KoranM A Jenike
May 15, 2002·Journal of Clinical Psychopharmacology·Deborah L Ackerman, Sander Greenland
Oct 28, 1998·Journal of Clinical Psychopharmacology·M N PotenzaC J McDougle
Apr 27, 2004·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·N UrracaH Nicolini
Feb 28, 2003·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·J ZoharD Amital
Dec 1, 2005·Expert Opinion on Pharmacotherapy·Bernardo Dell'OssoEric Hollander
Apr 17, 2008·Depression and Anxiety·Eric A StorchWayne K Goodman
Mar 23, 2007·Expert Opinion on Pharmacotherapy·Leonardo F FontenelleMarcio Versiani
Jan 20, 2009·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Y Y ShugartG Nestadt
Oct 1, 1995·Human Psychopharmacology·S J Van den Berg
Aug 14, 2018·Current Neuropharmacology·Antonio Del CasaleMaurizio Pompili
Oct 30, 2018·Current Neuropharmacology·Georgios D Kotzalidis On Behalf Of The Sapienza Group For The Study Of The Placebo Effect In Psychiatric Disorders
Apr 1, 1995·The British Journal of Psychiatry : the Journal of Mental Science·M PiccinelliG Wilkinson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.